Official UK procurement notice
Interim pathway to notify parents of a baby's Sickle Cell and other Haemoglobin carrier results identified under the NHS England Newborn bloodspot Screening (NBS) programme in Derbyshire [Urgent Award]
Authority: NHS England Midlands - East (NHS & healthcare)
What is being bought
Published requirement descriptionNHS England - Midlands (East) are making an urgent award for the Provision of Interim pathway to notify parents of Sickle Cell & other Haemoglobin carrier results identified during NBS Screening in Derbyshire.
CPV: Health services
The lotProcurement structure
single lot · no lot value publishedLot #1The contract is to deliver an interim pathway to notify parents of their babies Sickle…Awarded
The contract is to deliver an interim pathway to notify parents of their babies Sickle Cell & other Haemoglobin carrier results identified during NBS screening programme in Derbyshire.
NHS England - Midlands (East) are making an urgent award to the existing provider DHU Healthcare as described in regulation 14 of the Health Care Services (Provider Selection Regime) Regulations 2023.
Following an incident and audit, there was a clear recommendation for a clinical service to provide the Sickle Cell Carrier (SCC) results to babies born with a SCC. The responsibility for commissioning the clinical sickle cell carrier service sits with NHS Derby and Derbyshire Integrated Care Board (ICB), due to the timeframes to implement and recruit to the new service commissioned by the ICB, NHS England - Midlands (East) have agreed to commission this service on an interim basis until the permanent pathway is in place in January 2025. This date is subject to successful recruitment of staff for the ICB service therefore this contract will be let until 31st March 2025 and terminated early when the substantive service is operational.
This will ensure there is no gap in pathway provision. Failure to provide this service will further delay the sickle cell carrier status notification and other not suspected NBS results to parents of babies screened since 20th June 2024. It will create a health inequality as babies with other NBS results are notified in a shorter timeframe.
Therefore this contract is being awarded to DHU Healthcare as they are the current provider for the sickle cell serious incident response.
The lifetime value of this contract is £4,309.
Services will be provided between 4th November 2024 and 31st March 2025.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 5 Nov 2024, 17:42 GMT
- Last source update
- 5 Nov 2024, 17:42 GMT
- FTS notice number
2024/S 000-035854- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04b430Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Publisher note: This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The decision to use Regulation 14 to award under urgent circumstances was made due to the need to ensure there is no gap in pathway provision. Failure to provide this service will increase the backlog of babies waiting for results and create a health inequality as babies with other NBS results are notified in a shorter timeframe. There were no declared or potential conflicts of interest. The decision makers for this process are Midlands Commissioning Group (MCG).
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| DHU Healthcare | £4,309 † | — | Awarded |
Contracts
Contract 035854-2024-1-1 · DHU Healthcare
- Signed
- 1 Nov 2024
- Value
- £4,309
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- DHU HealthcareAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.